Original language | English (US) |
---|---|
Pages (from-to) | 734-737 |
Number of pages | 4 |
Journal | Pain Medicine (United States) |
Volume | 24 |
Issue number | 6 |
DOIs | |
State | Published - Jun 1 2023 |
Bibliographical note
Funding Information:Disclosures: J.M.H. is a consultant for Abbott, Boston Scientific, Nevro, and Saluda. He has funded research with Abbott, Medtronic, and Saluda. L.K. gets institutional research funding and consulting fees from Avanos. D.P.D. holds equity in, and serves as CMO of, StimSherpa, a neuromodulation company for pain. He receives funding from Abbott Labs. Other authors report no financial conflicts of interest.
PubMed: MeSH publication types
- Review
- Letter
- Research Support, Non-U.S. Gov't